Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic

This study has been terminated.
Sponsor:
Information provided by:
McMaster University
ClinicalTrials.gov Identifier:
NCT00248027
First received: November 1, 2005
Last updated: September 12, 2006
Last verified: September 2006
  Purpose

Main Research questions:

  1. Who are the patients referred for treatment at the Psychotic Disorders Clinic?
  2. What are the outcomes from treatment for first episode psychosis in multiple outcome domains?
  3. What hospital resources are used over the early course of the illness?
  4. How satisfied are patients and family with the treatment and services they received? This is an important study that will help us evaluate the service and treatment offered by the Psychotic Disorders Clinic's specialized early intervention program,which helps young people experiencing early stages of psychotic illness.A growing body of evidence suggests that intervening earlier in the course of the illness with specialized and complimentary pharmacological and psychosocial treatment may be associated with improved outcomes.

Condition Phase
Schizophreniform,First Episode Psychosis
Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic

Resource links provided by NLM:


Further study details as provided by McMaster University:

Study Start Date: January 2004
Detailed Description:

The project is primarily a descriptive study of individuals experiencing their first episode of psychosis presenting at the Psychotic Disorders Clinic/Early Intervention Program.

The objectives of the study are:

  1. Track multi-dimensional outcomes within the program
  2. Track service use
  3. Compare outcomes for this early intervention program with outcomes noted in published follow up studies
  4. Evaluate effectiveness of the Psychotic Disorders Clinic in improving outcomes for persons experiencing their first episode of psychosis
  Eligibility

Ages Eligible for Study:   16 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • male or female between ages of 16 to 50 years of age
  • capable of providing informed consent
  • receiving treatment voluntarily
  • experiencing a "first episode of psychosis" defined as the first episode of illness and where the subject,at presentation,meets DSM-IV criteria for one of the following diagnoses:schizophrenia,schizophreniform disorder,schizoaffective disorder,brief psychotic disorder,delusional disorder,and psychosis NOS

Exclusion Criteria:

  • primary diagnosis of mood disorder
  • diagnosis of substance-induced psychosis
  • diagnosis of psychosis due to a general medical condition
  • diagnosis of mental retardation
  • diagnosis of developmental disorder
  • has received antipsychotic treatment for greater than 1 month
  • has received treatment for an earlier episode of psychosis from which there has been a remission of symptoms for greater than 3 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00248027

Locations
Canada, Ontario
Cleghorn Program-Early Intervention in Psychosis.St Joseph's Healthcare Hamilton/Hamilton Health Sciences
Hamilton, Ontario, Canada, L8N 1Y2
Sponsors and Collaborators
Hamilton Health Sciences Corporation
Investigators
Principal Investigator: Suzanne Archie, MD,FRCP(C) Assistant Professor Dept of Psychiatry and Behavioural Neurosciences McMaster University.Active Medical Staff Hamilton Health Sciences.Clinical Director of Cleghorn Early Intervention in Psychosis Program and Psychotic Disorders Clinic
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00248027     History of Changes
Other Study ID Numbers: REB #04-203
Study First Received: November 1, 2005
Last Updated: September 12, 2006
Health Authority: Canada: Ethics Review Committee

Keywords provided by McMaster University:
early intervention,program evaluation

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on July 23, 2014